Cell-mediated immunity in mice infected with <i>Acanthamoeba culbertsoni</i>

, Kim, M J; , Shin, C O; , Im, K I

doi:1990.28.3.143

Korean J Parasito > Volume 28(3):1990 > Article

Original Article


Korean J Parasitol. 1990 Sep;28(3):143-154. English. Published online Mar 20, 1994. http://dx.doi.org/10.3347/kjp.1990.28.3.143
Copyright © 1990 by The Korean Society for Parasitology


Cell-mediated immunity in mice infected with Acanthamoeba culbertsoni
M J Kim,C O Shin and K I Im
Department of Parasitology, College of Medicine & Institute of Tropical Medicine, Yonsei University, Seoul 120-752, Korea.


Abstract
Observations were made on the differences of cell-mediated responses in mice of three infection groups differently scheduled in their severity with pathogenic Acanthamoeba culbertsoni. Infections were done by dropping 5 µl saline suspension containing 3 × 10³, 1 × 10⁴, or 1 × 10⁵ trophozoites, respectively. Amoebae were cultured axenically in CGV medium and inoculated into the right nasal cavity of C3H/HeJ mice aging around 6-8 weeks, under the anesthesia by intraperitoneal injection of secobarbital. Delayed type hypersensitivity (DTH) responses in footpad and blastogenic responses of mouse spleen cells using (³H)-thymidine and the serum antibody titer were measured up to day 14 after infection, and natural killer cell activities were measured up to day 5 after infection. The results obtained in this study were as follows: 1. The mice infected with 3 × 10³ trophozoites showed mortality rate of 17%, and 34% in the mice infected with 1 × 10⁴ trophozoites and 65% with 1 × 10⁵ trophozoites. 2. In regard to DTH responses in all experimental groups, the level increased on day 7 and declined on day 14 after infection, but their differences could not be noted between infected and control groups. 3. The blastogenic responses of splenocytes treated with amoeba lysates and lipopolysaccharides (LPS) showed no difference from the control group. The blastogenic responses of splenocytes treated with concanavalin A were declined significantly in the experimental group as compared with the control group, but the blastogenic responses of splenocytes treated with polyinosinic acid were not different from the control group. There was also no difference among three infected groups. 4. The cytotoxic activity of the natural killer cells was activated on day 1 after infection and declined to the level of control group on day 2 in all experimental groups. On day 5 after infection, the natural killer cell cytotoxicity was significantly suppressed as compared with the control groups. 5. The serum antibody titers of the infected mice increased after day 7, but there was no statistical difference between the three infected groups. In summary of the results, there was no difference in cell-mediated immune responses of three experimental groups scheduled with different infection intensities. But there was a significant difference in cell-mediated immune responses between infected and control mice. It is considered that cell-mediated immune responses should be involved in murine model infected with A. culbertsoni.

Figures


	Fig. 1 Survival rates of mice inoculated intranasally with A. culbertsoni.


	Fig. 2 Pattern of footpad swelling with A. culbertsoni lysates in mice infected with the amoeba.


	Fig. 3 Blastogenic response (stimulation index) of con. A or poly I treated splenocytes in A. culbertsoni infected mice and non-infected (control) mice.


	Fig. 4 Natural killer cell cytotoxicity against YAC-1 target cells in mice infected with A. culbertsoni.


	Fig. 5 Circulating antibody titers in mice infected with A. culbertsoni.

Tables


	Table 1 Cumulative number of death in mice inoculated untranasally with A. culbertsoni


	Table 2 Elicitation of footpad swelling with A. culbertsoni lysates in mice infected with the amoeba.


	Table 3 Blastogenic response (stimulation index) of the splenocytes treated with amoeba lysates in mice infected with A. culbertsoni and non-infected (control) mice


	Table 4 Blastogenic response (stimulation index) of the splenocytes treated with LPS in mice infected with A. culbertsoni and non-infected (control) mice


	Table 5 Blastogenic response (stimulation index) of the splenocytes treated with con. A or poly I in mice infected with 3×10³ trophozoites of A. culbertsoni and non-infected (control) mice


	Table 6 Blastogenic response (stimulation index) of the splenocytes treated with con. A or poly I in mice infected with 1×10⁴ trophozoites of A. culbertsoni and non-infected (control) mice


	Table 7 Blastogenic response (stimulation index) of the splenocytes treated with con. A or poly I in mice infected with 1×10⁵ trophozoites of A. culbertsoni and non-infected (control) mice


	Table 8 Natural killer cell cytotoxicity against YAC-1 target cells in mice infected with Acanthamoeba culbertsoni

References


1.	Barker LR. Experimental malaria: effects upon the immune response to different antigens. J Infect Dis 1971;123(1):99–101.

2.	Barbier D, Goyot P, Dedet JP. Leishmania braziliensis guyanensis dermal leishmaniasis: cell-mediated immunity related to clinical features. Trans R Soc Trop Med Hyg 1985;79(1):47–50.

3.	Bloom BR. In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol 1971;13:101–208.

4.	Bloom BR. Natural killers to rescue immune surveillance?. Nature 1982;300(5889):214–215.

5.	Britten V, Hudson L. Immune suppression to Trypanosoma cruzi antigens is associated with infection but not immunisation. Trop Med Parasitol 1986;37(2):97–100.

6.	Bryceson AD, Preston PM, Bray RS, Dumonde DC. Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol 1972;10(2):305–335.

7.	Carter RF. Primary amoebic meningo-encephalitis: clinical, pathological and epidemiological features of six fatal cases. J Pathol Bacteriol 1968;96(1):1–25.

8.	Cikes M, Friberg S Jr, Klein G. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst 1973;50(2):347–362.

9.	Clark IA, Allison AC. Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature 1974;252(5481):328–329.

*10.*	Cursons RT, Brown TJ, Keys EA, Moriarty KM, Till D. Immunity to pathogenic free-living amoebae: role of cell-mediated immunity. Infect Immun 1980;29(2):408–410.

*11.*	Cunningham DS, Kuhn RE. Trypanosoma cruzi-induced suppressor substance. I. cellular involvement and partial characterization. J Immunol 1980;124(5):2122–2129.

*12.*	Diamantstein T, Klos M, Gold D, Hahn H. Interaction between Entamoeba histolytica and the immune system. I. Mitogenicity of Entamoeba histolytica extracts for human peripheral T lymphocytes. J Immunol 1981;126(6):2084–2086.

*13.*	Diffley P, Skeels MR, Sogandares-Bernal F. Delayed type hypersensitivity in guinea pig infected subcutaneously with Naegleria fowleri Carter. Z Parasitenkd 1976;49(2):133–137.

*14.*	Boros DL, Warren KS. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970;132(3):488–507.

*15.*	Ferrante A, Rowan-Kelly B. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni. Clin Exp Immunol 1983;54(2):477–485.

*16.*	Ferrante A, Smyth C. Mitogenicity of Naegleria fowleri extract for murine T lymphocytes. Immunology 1984;51(3):461–468.

*17.*	Ferrante A, Thong YH. Antibody induced capping and endocytosis of surface antigens in Naegleria fowleri. Int J Parasitol 1979;9(6):599–601.

*18.*	Fowler M, Carter RF. Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report. Br Med J 1965;2(5464):740–742.

*19.*	Glode LM, Rosenstreich DL. Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles. J Immunol 1976;117(6):2061–2066.

*20.*	Glode LM, Scher I, Osborne B, Rosenstreich DL. Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice. J Immunol 1976;116(2):454–461.

*21.*	Greenwood BM, Playfair JH, Torrigiani G. Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol 1971;8(3):467–478.

*22.*	Hatcher FM, Kuhn RE. Destruction of Trypanosoma cruzi by Natural killer cells. Science 1982;218(4569):295–296.

*23.*	Hay J, Dutton GN, Hair DM. Blastogenic responses of splenic lymphocytes to toxoplasmal and retinal antigens and T- and B-cell mitogens in mice with congenital ocular toxoplasmosis. Ann Trop Med Parasitol 1985;79(1):113–115.

*24.*	Herberman RB, Holden HT. Natural cell-mediated immunity. Adv Cancer Res 1978;27:305–377.

*25.*	Herberman RB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science 1981;214(4516):24–30.

*26.*	Hersh EM, McCredie KB, Freireich EJ. Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts. Clin Exp Immunol 1974;17(3):463–473.

*27.*	Holbrook TW, Boackle RJ, Parker BW, Vesely J. Activation of the alternative complement pathway by Naegleria fowleri. Infect Immun 1980;30(1):58–61.

*28.*	Jacobson EB, Herzenberg LA. Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice. J Exp Med 1972;135(5):1151–1162.

*29.*	Kierszenbaum F. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J Immunol 1982;129(5):2202–2205.

*30.*	Kingston D, Warhurst DC. Isolation of amoebae from the air. J Med Microbiol 1969;2(1):27–36.

*31.*	Kramer M, Koszinowski U. T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function. J Immunol 1982;128(2):784–790.

*32.*	Lanier LL, et al. J Immunol 1986;137:4480–4484.

*33.*	Lanier LL, Phillips JH, Hackett J Jr, Tutt M, Kumar V. Natural killer cells: definition of a cell type rather than a function. J Immunol 1986;137(9):2735–2739.

*34.*	Lallinger GJ, Reiner SL, Cooke DW, Toffaletti DL, Perfect JR, Granger DL, Durack DT. Efficacy of immune therapy in early experimental Naegleria fowleri meningitis. Infect Immun 1987;55(5):1289–1293.

*35.*	Larsson EL, Iscove NN, Coutinho A. Two distinct factors are required for induction of T-cell growth. Nature 1980;283(5748):664–666.

*36.*	Liew FY. Cell-mediated immunity in experimental cutaneous Leishmaniasis. Parasitol Today 1986;2(10):264–270.

*37.*	Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193(1):265–275.

*38.*	Martinez J, Duma RJ, Nelson EC, Moretta FL. Experimental naegleria meningoencephalitis in mice. Penetration of the olfactory mucosal epithelium by Naegleria and pathologic changes produced: a light and electron microscope study. Lab Invest 1973;29(2):121–133.

*39.*	Michel JC, Lagrange PH, Hurtrel B. Modulation by malaria infection of the induction of T lymphocyte-dependent delayed-type hypersensitivity and antibody formation to sheep erythrocytes in mice. Parasite Immunol 1979;1(4):267–275.

*40.*	Ortaldo JR, Herberman RB. Heterogeneity of natural killer cells. Annu Rev Immunol 1984;2:359–394.

*41.*	Ramos C, Schadtler-Siwon I, Ortiz-Ortiz L. Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice. J Immunol 1979;122(4):1243–1247.

*42.*	Reynolds CW, Timonen T, Herberman RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 1981;127(1):282–287.

*43.*	Richards CS. Two new species of Hartmannella amebae infecting freshwater mollusks. J Protozool 1968;15(4):651–656.

*44.*	Rowan-Kelly B, Ferrante A, Thong YH. Activation of complement by Naegleria. Trans R Soc Trop Med Hyg 1980;74(3):333–336.

*45.*	Salaman MH, Wedderburn N, Bruce-Chwatt LJ. The immunodepressive effect of a murine plasmodium and its interaction with murine oncogenic viruses. J Gen Microbiol 1969;59(3):383–391.

*46.*	Schurr E, Kidane K, Yemaneberhan T, Wunderlich F. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre. Trop Med Parasitol 1986;37(4):403–408.

*47.*	Selkirk ME, Ogilvie BM, Platts-Mills TA. Activation of human peripheral blood lymphocytes by a trypanosome-derived mitogen. Clin Exp Immunol 1981;45(3):615–620.

*48.*	Sengers RC, Jerusalem CR, Doesburg WH. Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection. Exp Parasitol 1971;30(1):41–53.

*49.*	Strickland GT, Ahmed A, Sell KW. Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin Exp Immunol 1975;22(1):167–176.

*50.*	Suzuki Y, Kobayashi A. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. I. Inhibition of proliferation of lymphocytes in primary antibody responses. Cell Immunol 1984;85(2):417–427.

*51.*	Thong YH, Ferrante A, Rowan-Kelly B, O'Keefe DE. Immunization with culture supernatant in experimental amoebic meningoencephalitis. Trans R Soc Trop Med Hyg 1979;73(6):684–685.

*52.*	Thong YH, Ferrante A, Rowan-Kelly B, O'Keefe DE. Immunization with culture supernatant in experimental amoebic meningoencephalitis. Trans R Soc Trop Med Hyg 1979;73(6):684–685.

*53.*	Thong YH, Ferrante A, Shepherd C, Rowan-Kelly B. Resistance of mice to Naegleria meningoencephalitis transferred by immune serum. Trans R Soc Trop Med Hyg 1978;72(6):650–652.

*54.*	Timonen T, Reynolds CW, Ortaldo JR, Herberman RB. Isolation of human and rat natural killer cells. J Immunol Methods 1982;51(3):269–277.

*55.*	Trischmann T, Tanowitz H, Wittner M, Bloom B. Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp Parasitol 1978;45(2):160–168.

*56.*	Ullberg M, Jondal M. Recycling and target binding capacity of human natural killer cells. J Exp Med 1981;153(3):615–628.

*57.*	Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ 1976;53(1):55–65.

*58.*	Wright SC, Bonavida B. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines. J Immunol 1984;133(6):3415–3423.